On Tuesday, April 4th, 2023, the US FDA granted Inflarx NV’s IF0G.F monoclonal antibody emergency-use authorization for the treatment of hospitalized COVID patients when initiated within 48 hours of receiving artificial life support. The US recorded portions of the German biopharmaceutical organization rose practically 25% to $4.70 after the ringer. Gohibic is an injection that […]
Continue Reading
In a move that could help one of the most important pollinators on the planet, the US Department of Agriculture approved the first vaccine developed in the United States to combat the global decline in honeybee populations. The vaccine may be available later this year. The vaccine targets the bacteria that are attributed to the […]
Continue Reading
Pfizer and BioNTech has submitted an application to the US Food and Drug Administration (FDA) for emergency use authorization of the Omicron-adapted COVID-19 vaccine booster for children under 5 years. If the vaccine is authorized, the children would receive the primary series of the vaccine consisting of two doses of the original COVID-19 vaccine developed […]
Continue Reading
The Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom has approved Nuvaxovid, the COVID-19 vaccine developed by Novavax, for 12 to 17 year old children. This approval follows a review of the safety, effectiveness, and quality of the COVID-19 vaccine in the particular age group, and the expert advice from the independent […]
Continue Reading
The US Food and Drug Administration (FDA) has approved the COVID-19 vaccine developed by Novavax for emergency use in teenagers between the ages of 12 to 17 years. Besides the emergency use authorisation, the COVID-19 vaccine will also be offered as a two-dose primary series for US teenagers. This authorization is considered to be the […]
Continue Reading
BioNTech, a German biotech company, said it is expecting to start deliveries of two Omicron-adapted vaccines as soon as October 2022, which will help the growing demand in the fourth quarter of 2022. The demand for the COVID-19 vaccine, and 3.6 doses of which have been shipped across the globe, is currently waning as most […]
Continue Reading
The US Department of Health and Human Services (HHS), in partnership with the US Department of Defense (DOD), announced an agreement to purchase 66 million doses of bivalent COVID-19 vaccine booster candidates by Moderna for potential use in winter and fall. This announcement of a contract follows a recommendation by the US FDA that vaccine […]
Continue Reading
The Department of Health and Human Services (HHS) announced, the government of the United States plans an enhanced nationwide vaccination strategy for the purpose of fighting the Monkeypox disease. The HHS department, said the strategy will protect and vaccinate those people, who are at-risk of contracting Monkeypox and will prioritize vaccines for areas with high […]
Continue Reading
According to a study conducted in the United Kingdom, a third dose of the novel corona virus vaccine of AstraZeneca has been effective against the symptomatic disease and hospitalization, which will be offering protection comparable to a booster covid-19 shot of the preventive of Pfizer. The study has also assessed the effectiveness of the corona […]
Continue Reading
On Thursday, 28th April 2022, the Food and Drug Administration (FDA) of the United States for the purpose of authorizing the corona virus vaccine for the children between the age group of 6 months to 5 years. The covid-19 vaccine had been around 51 percent effective against the corona virus infection from the omicron variant […]
Continue Reading